Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on

Novartis is pawning off manufacturing operations on both sides of the Atlantic.

First, the company has reached a deal to sell its Ringaskiddy campus near Cork, Ireland, to contract manufacturer Sterling Pharma Solutions. Separately, CDMO compatriot Delpharm has completed its acquisition of a Quebecois manufacturing plant from Novartis’ generics unit, Sandoz.